Market Pulse LIVECAST Terminal Brief Politics Macro Calendar

More

Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Market Pulse LIVECAST

Menu

Home Market Pulse LIVECAST Terminal Brief Politics Macro Calendar Stocks About Why SquawkNews Newsroom Schedule Prediction Markets Disclosure Wire Crypto Search

Live News EARNINGS H impact Jul 09, 2026, 10:00 AM UTC

$PEP Pepsi Q2 2026 Earnings

$PEP Pepsi Q2 2026 Earnings

SQUAWKNEWS Updated Jul 09, 2026, 10:00 AM UTC

$PEP Pepsi Q2 2026 Earnings

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

PEP

Related stories

Trump’s $4 Billion Oklahoma Project Paused, ‘Build It in Mar-A-Lago’ Community Says Inola, Oklahoma – a small rural community known as the "Hay Capital of the World" has become a center of President Donald Trump’s push to rebuild the American aluminum industry. Th H impact | EARNINGS | Jul 09, 2026, 11:11 AM UTC Earnings Flash (KITS.TO) Kits Eyecare Ltd. Reports Q2 Revenue C$58.2M H impact | EARNINGS | Jul 09, 2026, 11:10 AM UTC Simply Good Foods Raises FY2026 Sales Guidance from $1.310B-$1.350B to $1.345B-$1.355B vs $1.334B Est Simply Good Foods (NASDAQ: SMPL ) raises FY2026 sales outlook from $1.310 billion-$1.350 billion to $1.345 billion-$1.355 billion vs $1.334 billion estimate. H impact | EARNINGS | Jul 09, 2026, 11:06 AM UTC Neo Performance Materials Boosts 2026 Adjusted EBITDA Guidance Neo Performance Materials (NEO.TO) increased its full-year 2026 adjusted EBITDA guidance by 38% at the midpoint, the company said Wednesday. Adjusted EBITDA for 2026 is now forecas H impact | EARNINGS | Jul 09, 2026, 11:02 AM UTC West Pharmaceutical price target raised to $365 from $325 at Morgan Stanley Morgan Stanley raised the firm's price target on West Pharmaceutical to $365 from $325 and keeps an Equal Weight rating on the shares. The firm is updating its model ahead of the e H impact | EARNINGS | Jul 09, 2026, 11:01 AM UTC Personalis price target raised to $13 from $9 at Morgan Stanley Morgan Stanley analyst Kallum Titchmarsh raised the firm's price target on Personalis to $13 from $9 and keeps an Equal Weight rating on the shares. The firm is updating its model H impact | EARNINGS | Jul 09, 2026, 10:59 AM UTC

SQUAWK/NEWS

Real-time financial news agency. Market-moving headlines, macro, politics, filings and audio squawk built for traders.

Product

LiveCast
Terminal
Brief
Macro
Calendar
Search

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact

© 2026 SquawkNews robots / sitemap SquawkNews publishes factual market information and context. It is not investment advice and does not provide trade recommendations.